Macular degeneration: open trials in Hungary

13 open trials have a site in Hungary. Registry data; only the trial team decides who can take part.

NCT06541704
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Budapesti Jahn Ferenc Del-pesti Korhaz es Rendelointezet, Budapest · Central Hospital Of Northern Pest Military Hospital, Budapest VI · Semmelweis University, Budapest VIII · Budapest Retina Associates Kft., Budapest XIII · University of Debrecen, Debrecen · Nozologen Kft., Pécs · University of Szeged, Szeged · Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz, Szombathely
Registry updated 2026-11-05
NCT06635148
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Central Hospital Of Northern Pest Military Hospital, Budapest VI · Nozologen Kft., Pécs · Zala Varmegyei Szent Rafael Korhaz, Zalaegerszeg
Registry updated 2026-11-03
NCT07007065
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Trial Treatment · Phase 3 · AbbVie
Semmelweis University, Budapest VIII · Budapest Retina Associates Kft., Budapest XIII · University of Debrecen, Debrecen · Nozologen Kft., Pécs
Registry updated 2026-10-29
NCT07064759
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Trial Treatment · Phase 3 · 4D Molecular Therapeutics
Budapest Retina Associates, Budapest · Bajcsy-Zsilinszky Kórház, Budapest · Semmelweis Egyetem - Szemészeti Klinika, Budapest · DE KK Ophthalmology Clinic, Debrecen · Ganglion Medical Center, Pécs · SzTE SZAKK Szemeszeti Klinika, Szeged
Registry updated 2026-10-19
NCT07614776
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Trial Treatment · Phase 3 · Amgen
Budapesti Jahn Ferenc Del-pesti Korhaz es Rendelointezet, Budapest · Central Hospital Of Northern Pest Military Hospital, Budapest VI · Semmelweis University, Budapest VIII · Budapest Retina Associates Kft., Budapest XIII · University of Debrecen, Debrecen · Nozologen Kft., Pécs · University of Pecs, Pécs · University of Szeged, Szeged · Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz, Szombathely · Zala Varmegyei Szent Rafael Korhaz, Zalaegerszeg
Registry updated 2026-10-14
NCT07441642
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Budapest · Debrecen · Pécs
Registry updated 2026-10-13
2026-526648-11-00
A Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like “trap” in Participants with Neovascular Age-Related Macular Degeneration with or without Geographic Atrophy – STAT Study
Trial Treatment · Phase 2/3 · Shenzhen Oculgen Biomedical Technology Co. Ltd.
Budapesti Bajcsy-Zsilinszky Korhaz Es Rendelointezet, Budapest · Budapesti Jahn Ferenc Del-pesti Korhaz es Rendelointezet, Budapest · Semmelweis University, Budapest VIII · University of Debrecen, Debrecen · University of Pecs, Pécs · Nozologen Kft., Pécs · University of Szeged, Szeged
Registry updated 2026-09-25
2025-524894-17-00
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
Trial Treatment · Phase 2/3 · Eyebiotech Limited
Budapesti Jahn Ferenc Del-pesti Korhaz es Rendelointezet, Budapest · Central Hospital Of Northern Pest Military Hospital, Budapest VI · Semmelweis University, Budapest VIII · Budapesti Bajcsy-Zsilinszky Korhaz Es Rendelointezet, Budapest X · Budapest Retina Associates Kft., Budapest XIII · University of Debrecen, Debrecen · Nozologen Kft., Pécs · University of Szeged, Szeged · Zala Varmegyei Szent Rafael Korhaz, Zalaegerszeg
Registry updated 2026-09-10
NCT06659445
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Trial Treatment · Phase 2 · ONL Therapeutics
Budapesti Bajcsy-Zsilinszky Korhaz Es Rendelointezet, Budapest · Budapesti Jahn Ferenc Del-pesti Korhaz es Rendelointezet, Budapest · Central Hospital Of Northern Pest Military Hospital, Budapest VI · Semmelweis University, Budapest VIII · Budapest Retina Associates Kft., Budapest XIII · University of Debrecen, Debrecen · University of Pecs, Pécs · University of Szeged, Szeged
Registry updated 2026-09-10
NCT06990269
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Trial Treatment · Phase 2 · ADARx Pharmaceuticals, Inc.
Budapest · Debrecen · Pécs
Registry updated 2026-09-03
NCT07496567
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Trial Treatment · Phase 2/3 · EyeBiotech Ltd.
Budapest Retina Associates, Budapest
Registry updated 2026-08-06
2025-523704-77-00
A clinical trial to learn more about the effects of FWY003 in people with geographic atrophy associated with age-related macular degeneration.
Trial Treatment · Phase 2 · Novartis Pharma AG
Central Hospital Of Northern Pest Military Hospital, Budapest VI · Semmelweis University, Budapest VIII · Budapest Retina Associates Kft., Budapest XIII · University of Debrecen, Debrecen · Nozologen Kft., Pécs
Registry updated 2026-06-23
NCT03999801
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
Trial Treatment · Phase 2 · AbbVie
Budapest Retina Associates Kft., Budapest XIII · University of Debrecen, Debrecen · Nozologen Kft., Pécs
Registry updated 2024-06-17

All Macular degeneration trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error